The latest closing stock price for Viking Therapeutics as of September 18, 2024 is 64.45.
An investor who bought $1,000 worth of Viking Therapeutics stock at the IPO in 2015 would have $6,193 today, roughly 6 times their original investment - a 24.51% compound annual growth rate over 9 years.
The all-time high Viking Therapeutics stock closing price was 94.50 on February 28, 2024.
The Viking Therapeutics 52-week high stock price is 99.41, which is 54.2% above the current share price.
The Viking Therapeutics 52-week low stock price is 8.28, which is 87.2% below the current share price.
The average Viking Therapeutics stock price for the last 52 weeks is 44.08.
An investor who bought $1,000 worth of Viking Therapeutics stock at the IPO in 2015 would have $6,193 today, roughly 6 times their original investment - a 24.51% compound annual growth rate over 9 years.
The all-time high Viking Therapeutics stock closing price was 94.50 on February 28, 2024.
The Viking Therapeutics 52-week high stock price is 99.41, which is 54.2% above the current share price.
The Viking Therapeutics 52-week low stock price is 8.28, which is 87.2% below the current share price.
The average Viking Therapeutics stock price for the last 52 weeks is 44.08.